Infectious disease specialist and vaccinologist Yevgeny Timakov did not rule out that the new Russian vaccine against COVID-19 “KoviVac may be suitable for children,” writes Izvestia newspaper.
He explained that this is due to the classical technology for the production of the drug.
“The vaccine against poliomyelitis and tick-borne encephalitis has been made on the same basis. At the same time, I believe that it is too early to test the drug on children: there are no final clinical trials on adults, ”the expert said.
Recall that on February 20, Russian Prime Minister Mikhail Mishustin announced the registration of the third Russian vaccine against coronavirus, developed by the Chumakov Center. According to him, already in mid-March, the first 120 thousand doses of the drug “KoviVac” will be launched into civil circulation. Note that a specialist consultation is required before using the vaccine.
“CoviVac” differs from other vaccines in that it mimics the body’s natural process of fighting the virus as a whole, and not only blocks its S-protein. The publication notes that the new vaccine used the whole virus, therefore, according to experts, it may be effective against mutated strains of SARS-CoV-2.
Earlier, RAS Corresponding Member Aydar Ishmukhametov said that research on the Kovivac vaccine for its use among children and people over 60 is planned to begin in April.
The combined vector vaccine “Sputnik V” and the peptide vaccine “EpiVacCorona” are also registered in the Russian Federation. Earlier, the AIF created a comparative table of drugs for coronavirus.